521275 | PDK1/Akt/Flt Dual Pathway Inhibitor - CAS 331253-86-2 - Calbiochem

521275
Le prix n'a pas pu être récupéré
Minimum Quantity needs to be mulitiple of
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée Disponibilité limitée
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Remaining : Will advise
      Nous vous tiendrons informé
      Voir les Prix & la Disponibilité
         ComparerClick To Print This Page

      Overview

      Replacement Information

      Tableau de caractéristiques principal

      Empirical Formula CAS #
      C₁₀H₄N₆O 331253-86-2

      Prix & Disponibilité

      RéférenceDisponibilité Conditionnement Qté Prix Quantité
      521275-5MG
      Récupération des données relatives à la disponibilité...
      Disponibilité limitée Disponibilité limitée
      Interrompu(e)
      Disponible en quantités limitées
      Disponibilité à confirmer
        Remaining : Will advise
          Nous vous tiendrons informé

          5 mg
          Prix en cours de récupération
          Le prix n'a pas pu être récupéré
          Minimum Quantity needs to be mulitiple of
          À la validation de la commande Plus d'informations
          Vous avez sauvegardé ()
           
          Demander le prix
          Description
          Overview A cell-permeable compound that selectively induces apoptosis in AML (Acute Myelogenous Leukemia) with little effect on normal CD34+ AML progenitor cells. Shown to directly inhibit both PDK1 and Akt activities in in vitro kinase assays in a dose-dependent manner and block cellular phosphorylation of Akt at both Ser473 and Thr308. The dual inhibition nature against both PDK1/Akt and Flt3/PIM signaling pathways allows effective killing of AML cells (Average IC50 = 1.05, 1.91, and 0.43 µM for AML with wild-type Flt3, single mutant ITD/D835, and double mutant Flt3-ITD-TDK, respectively) that are otherwise resistant to inhibitors that target only the PDK1/Akt pathway.
          CAS. Nos. 331253-86-2 and 329710-24-9 (two isomers)
          Catalogue Number 521275
          Brand Family Calbiochem®
          Synonyms 6H-Indeno[1,2-e]tetrazolo[1,5-b][1,2,4]triazin-6-one & 10H-Indeno[2,1-e]tetrazolo[1,5-b][1,2,4]triazin-10-one, Akt Inhibitor XXI, PDK1 Inhibitor I, KP372-1
          References
          References Zeng, Z., et al. 2006. Cancer Res. 66, 3737.
          Koul, D., et al. 2006. Mol. Cancer Ther. 5, 637.
          Mandal. M., et al. 2006. Oral Oncol. 42, 430.
          Mandal. M., et al. 2005. Br. J. Cancer 92, 1899.
          Product Information
          CAS number 331253-86-2
          ATP Competitive N
          Form Yellow solid
          Hill Formula C₁₀H₄N₆O
          Chemical formula C₁₀H₄N₆O
          Molar Mass 224.2
          Reversible N
          Structure formula Image
          Applications
          Biological Information
          Primary Target Both PDK1 and Akt activities
          Primary Target IC50 1.05, 1.91, and 0.43 µM for AML with wild-type Flt3, single mutant ITD/D835, and double mutant Flt3-ITD-TDK, respectively
          Purity ≥98% by HPLC (sum of two isomers)
          Physicochemical Information
          Cell permeable Y
          Solubility DMSO
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          R Phrase R: 36/37/38

          Irritating to eyes, respiratory system and skin.
          S Phrase S: 26-36

          In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
          Wear suitable protective clothing.
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Irritant
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          FDS

          Langues
          Australia Canadian English Canadian French
          Colombia Danmark Deutschland
          Ellas English España
          France Italia Korea
          Magyarország Nederland  Norge
          Polska Portugal Suomi
          Sverige US Español Österreich
          България

          Certificats d'analyse

          TitreNuméro de lot
          521275

          Références bibliographiques

          Aperçu de la référence bibliographique
          Zeng, Z., et al. 2006. Cancer Res. 66, 3737.
          Koul, D., et al. 2006. Mol. Cancer Ther. 5, 637.
          Mandal. M., et al. 2006. Oral Oncol. 42, 430.
          Mandal. M., et al. 2005. Br. J. Cancer 92, 1899.
          Fiche technique

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision 18-April-2011 RFH
          Synonyms 6H-Indeno[1,2-e]tetrazolo[1,5-b][1,2,4]triazin-6-one & 10H-Indeno[2,1-e]tetrazolo[1,5-b][1,2,4]triazin-10-one, Akt Inhibitor XXI, PDK1 Inhibitor I, KP372-1
          Description A cell-permeable compound that selectively induces apoptosis in AML (Acute Myelogenous Leukemia) with little effect on normal CD34+ AML progenitor cells. Shown to directly inhibit both PDK1 and Akt activities in in vitro kinase assays in a dose-dependent manner and block cellular phosphorylation of Akt at both Ser473 and Thr308. The dual inhibition nature against both PDK1/Akt and Flt3/PIM signaling pathways allows effective killing of AML cells (Average IC50 = 1.05, 1.91, and 0.43 µM for AML with wild-type Flt3, single mutant ITD/D835, and double mutant Flt3-ITD-TDK, respectively) that are otherwise resistant to inhibitors that target only the PDK1/Akt pathway. CAS. No. 331253-86-2 and 329710-24-9.
          Form Yellow solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number 331253-86-2
          Molar mass 224.2
          Chemical formula C₁₀H₄N₆O
          Structure formula
          Purity ≥98% by HPLC (sum of two isomers)
          Solubility DMSO (10 mg/ml)
          Storage +2°C to +8°C
          Protect from light
          Do Not Freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Toxicity Irritant
          References Zeng, Z., et al. 2006. Cancer Res. 66, 3737.
          Koul, D., et al. 2006. Mol. Cancer Ther. 5, 637.
          Mandal. M., et al. 2006. Oral Oncol. 42, 430.
          Mandal. M., et al. 2005. Br. J. Cancer 92, 1899.